FDA Limits Multiproduct Comparisons In 510(k) Submissions
The U.S. Food and Drug Administration on Friday updated its approach to determining whether new medical devices are "substantially equivalent" to previously approved products and eligible for so-called 510(k) clearance, partly...To view the full article, register now.
Already a subscriber? Click here to view full article